Translational Research in Oncology   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Edmonton Canada (1997)

Organization Overview

First Clinical Trial
2009
NCT00718523
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Translational Research in Oncology | Translational Research in Oncology-U.S